Managing Nicotine Withdrawal from Vaping

Introduction to Vaping Cessation

The American College of Cardiology recommends starting combination nicotine replacement therapy immediately with a 21 mg nicotine patch plus 4 mg nicotine gum or lozenges, paired with at least 4 sessions of behavioral counseling over 12 weeks 1, 2

Nicotine withdrawal from vaping follows the same physiological pattern as cigarette smoking, with symptoms beginning within 24 hours of last use, peaking at 3-4 days, and typically persisting for 3-4 weeks 1
Common symptoms of nicotine withdrawal include cigarette/vaping cravings, anxiety, irritability, and restlessness 1, 3
Increased appetite and weight gain are also common, with an average weight gain of 2.8-3.8 kg 1

Combination nicotine replacement therapy is nearly 3 times more effective than placebo and 25% more effective than single-form NRT 1, 2
The recommended dosing protocol includes a 21 mg nicotine patch applied daily for 24-hour steady nicotine delivery, paired with a short-acting component such as 4 mg nicotine gum or lozenges 1, 2

Combining medication with behavioral counseling is significantly more effective than either alone, with an odds ratio of 3.25 4, 2
Behavioral intervention components include reflective listening, exploring the meaning of vaping behavior, identifying specific vaping triggers, and developing personalized coping strategies 1, 2

If combination NRT fails or is contraindicated, alternative options include varenicline, cytisinicline, and bupropion 1, 4
Varenicline is equally effective as combination NRT, while cytisinicline has shown promise in recent trials 1, 4

Adolescents under 18 years old require special consideration, as there are no FDA-approved medications for tobacco/e-cigarette cessation in this age group 5, 6
Patients with cardiovascular disease require closer monitoring during withdrawal due to autonomic imbalance, and beta-blockers may be useful for managing withdrawal-related tachycardia 3
Hospitalized patients should be assessed for vaping status on admission and provided with pharmacotherapy during hospitalization to improve comfort and promote cessation after discharge 1